Cowen Maintains Buy on TransMedics Group, Inc. (TMDX) March 2026

On March 16, 2026, Cowen & Co. maintained a Buy on TransMedics Group, Inc. (TMDX), marking a steady position from the firm. The TMDX analyst rating update arrived at 09:37 AM and referenced a new label tied to soon-to-be-published data. Cowen left no new price target in the note. This maintained rating followed modest intraday moves, with a 0.08% rise equal to $0.1 since the update.